Main > A1. CORP. INDEX. In-Iz > Ipsen Pharma./P C2

---

This data is not available for free

Ipsen Pharma./P C2's subsections
2008. 01.31.2008. Cervical Dystonia
2008. 03.17.2008. Aesthetics
2009. 06.15.2009. PharNext
2010. 03.23.2010. GTX Inc.
2012. 01.05.2012. Oncodesign PD
2012. 07.11.2012. Retain Dreux Site
2013. 02.07.2013. Bowel Cleansing
2013. 07.15. Acq. Syntaxin
2013. 07.15. Harvard Medical
2013. 09.17. Onco.>NET
2013. 09.26. USA>R&D
2013. 12.18. Mayoly Spindler
2014. 02.07. Onco.>Prostate C.
2014. 03.18. Uro.>InContinence>NDO
2014. 10.22. Onco.>Carcinoid Syndr.
2014. 11.06. Endo.>Acromegaly
2015. 02.24. Acq Canbex Therap.
2015. 07.16. Upper Limb Spasticity
2016. 08.01. Lower Limb Spasticity
2016. 09.14. Onco.>RCC
2017. 01.08. Acq. Merrimack>Onco.
2017. 04.03. Acq. Merrimack>Onco
2017. 06.16. Lower Limb Spasticity
2017. 07.03. Onco.>NET
2017. 09.10. Onco.>Carcinoid ..
2017. 09.19. Onco.>Carcinoid ..
2018. 05.29. Onco.>MD Anderson
2019. 06.24. Onco.>GEP-NETs
2021. 03.16. SPIGFD>Mecasermin>CA
2021. 08.02. Neuro.>Exicure
2021. 10.18. Onco.>Accent Therapeut
2022. 01.24. Rare>FOP>CA>OK
2022. 06.27. Acq. Epizyme
2022. 08.12. Acq. Epizyme
2023. 01.09. Acq. Albireo
2023. 03.02. Acq. Albireo
2023. 06.13. U.S. FDA approves
2023. 08.16. Rare>FOP>USA>OK
Beaufour Laboratories/P
BioMeasure Inc./P
Ipsen Ltd./P
Societé Conseils (SCRAS)/P
Sterix Ltd./P
Web-Site
Z - OK

Ipsen Pharma./P C2's products
This section has no products